(±)-Lisofylline
Product Specifications
Product Name Alternative
(±)-Lisophylline
UNSPSC Description
(±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research[1].
Target Antigen
Interleukin Related
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/racemic-lisofylline.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1CCCCC(O)C)N(C)C2=C(N(C)C=N2)C1=O
Molecular Weight
280.328
References & Citations
[1]Yang Z, et al. Lisofylline: a potential lead for the treatment of diabetes. Biochem Pharmacol. 2005 Jan 1;69(1):1-5.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126042/racemic-Lisofylline-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126042/racemic-Lisofylline-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
6493-06-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1006592-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Silenced mating-type protein ALPHA1 (HMLALPHA1)
Ask
View Details